First Time Loading...

Medistim ASA
OSE:MEDI

Watchlist Manager
Medistim ASA Logo
Medistim ASA
OSE:MEDI
Watchlist
Price: 175 NOK -0.57% Market Closed
Updated: May 16, 2024

Intrinsic Value

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. [ Read More ]

The intrinsic value of one MEDI stock under the Base Case scenario is 189.57 NOK. Compared to the current market price of 175 NOK, Medistim ASA is Undervalued by 8%.

Key Points:
MEDI Intrinsic Value
Base Case
189.57 NOK
Undervaluation 8%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Medistim ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling MEDI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Medistim ASA

Provide an overview of the primary business activities
of Medistim ASA.

What unique competitive advantages
does Medistim ASA hold over its rivals?

What risks and challenges
does Medistim ASA face in the near future?

Summarize the latest earnings call
of Medistim ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Medistim ASA.

Provide P/S
for Medistim ASA.

Provide P/E
for Medistim ASA.

Provide P/OCF
for Medistim ASA.

Provide P/FCFE
for Medistim ASA.

Provide P/B
for Medistim ASA.

Provide EV/S
for Medistim ASA.

Provide EV/GP
for Medistim ASA.

Provide EV/EBITDA
for Medistim ASA.

Provide EV/EBIT
for Medistim ASA.

Provide EV/OCF
for Medistim ASA.

Provide EV/FCFF
for Medistim ASA.

Provide EV/IC
for Medistim ASA.

Show me price targets
for Medistim ASA made by professional analysts.

What are the Revenue projections
for Medistim ASA?

How accurate were the past Revenue estimates
for Medistim ASA?

What are the Net Income projections
for Medistim ASA?

How accurate were the past Net Income estimates
for Medistim ASA?

What are the EPS projections
for Medistim ASA?

How accurate were the past EPS estimates
for Medistim ASA?

What are the EBIT projections
for Medistim ASA?

How accurate were the past EBIT estimates
for Medistim ASA?

Compare the revenue forecasts
for Medistim ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Medistim ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medistim ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medistim ASA compared to its peers.

Compare the P/E ratios
of Medistim ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Medistim ASA with its peers.

Analyze the financial leverage
of Medistim ASA compared to its main competitors.

Show all profitability ratios
for Medistim ASA.

Provide ROE
for Medistim ASA.

Provide ROA
for Medistim ASA.

Provide ROIC
for Medistim ASA.

Provide ROCE
for Medistim ASA.

Provide Gross Margin
for Medistim ASA.

Provide Operating Margin
for Medistim ASA.

Provide Net Margin
for Medistim ASA.

Provide FCF Margin
for Medistim ASA.

Show all solvency ratios
for Medistim ASA.

Provide D/E Ratio
for Medistim ASA.

Provide D/A Ratio
for Medistim ASA.

Provide Interest Coverage Ratio
for Medistim ASA.

Provide Altman Z-Score Ratio
for Medistim ASA.

Provide Quick Ratio
for Medistim ASA.

Provide Current Ratio
for Medistim ASA.

Provide Cash Ratio
for Medistim ASA.

What is the historical Revenue growth
over the last 5 years for Medistim ASA?

What is the historical Net Income growth
over the last 5 years for Medistim ASA?

What is the current Free Cash Flow
of Medistim ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medistim ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medistim ASA

Current Assets 414.2m
Cash & Short-Term Investments 170.3m
Receivables 86.6m
Other Current Assets 157.4m
Non-Current Assets 114.1m
PP&E 61.6m
Intangibles 48m
Other Non-Current Assets 4.5m
Current Liabilities 85.9m
Other Current Liabilities 85.9m
Non-Current Liabilities 12.6m
Long-Term Debt 9.1m
Other Non-Current Liabilities 3.5m
Efficiency

Earnings Waterfall
Medistim ASA

Revenue
530.9m NOK
Cost of Revenue
-111.4m NOK
Gross Profit
419.5m NOK
Operating Expenses
-289.5m NOK
Operating Income
130.1m NOK
Other Expenses
-27.5m NOK
Net Income
102.5m NOK

Free Cash Flow Analysis
Medistim ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MEDI Profitability Score
Profitability Due Diligence

Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
72/100
Profitability
Score

Medistim ASA's profitability score is 72/100. The higher the profitability score, the more profitable the company is.

MEDI Solvency Score
Solvency Due Diligence

Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Medistim ASA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MEDI Price Targets Summary
Medistim ASA

Wall Street analysts forecast MEDI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MEDI is 193.8 NOK with a low forecast of 191.9 NOK and a high forecast of 199.5 NOK.

Lowest
Price Target
191.9 NOK
10% Upside
Average
Price Target
193.8 NOK
11% Upside
Highest
Price Target
199.5 NOK
14% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MEDI Price
Medistim ASA

1M 1M
-6%
6M 6M
-12%
1Y 1Y
-39%
3Y 3Y
-34%
5Y 5Y
+40%
10Y 10Y
+784%
Annual Price Range
175
52w Low
173.1113
52w High
292
Price Metrics
Average Annual Return 24.08%
Standard Deviation of Annual Returns 43.87%
Max Drawdown -55%
Shares Statistics
Market Capitalization 3.2B NOK
Shares Outstanding 18 269 000
Percentage of Shares Shorted
N/A

MEDI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Medistim ASA Logo
Medistim ASA

Country

Norway

Industry

Health Care

Market Cap

3.2B NOK

Dividend Yield

2.54%

Description

Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

Contact

OSLO
Oslo
Okernveien 94
+4723059660.0
http://www.medistim.com/

IPO

2004-05-28

Employees

118

Officers

CEO & President
Ms. Kari Eian Krogstad
Chief Financial Officer
Mr. Thomas Jakobsen
Vice President of Operations & Manufacturing
Mr. Helge Borslid
Vice President of Marketing
Ms. Hæge Johanne Krogh Wetterhus
Chief Innovation Officer
Mr. Hakon Grothe
Chief Business Development Officer
Mr. Ole Arne Eiksund
Show More
Managing Director of Medistim Norge AS
Mr. Ole Jorgen Robsrud
President of Medistim USA Inc
Mr. Mike Farbelow
Vice President of Sales - APAC
Mr. Roger Reino Morberg
Vice President of Sales EMEA
Ms. Stephanie D'Avout Stenhagen
Show Less

See Also

Discover More
What is the Intrinsic Value of one MEDI stock?

The intrinsic value of one MEDI stock under the Base Case scenario is 189.57 NOK.

Is MEDI stock undervalued or overvalued?

Compared to the current market price of 175 NOK, Medistim ASA is Undervalued by 8%.